Metabasis, Merck Reach R&D Pact
Metabasis Therapeutics (MBRX) and Merck (MRK) agreed to work together to research, develop and commercialize novel small molecule therapeutics with the potential to treat several diseases, including type II diabetes and obesity.
Both companies will offer drug candidates to the collaboration. Merck will make a payment of $5 million and provide Metabasis with funding for its research contribution to the program.
Additionally, Merck will assume the primary responsibility, including financial responsibility, for clinical development and will have the right to market products worldwide.
Metabasis could get added payments throughout the course of the pact. Shares of Metabasis, a biopharmaceutical company, were down 15 cents to $3.04.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV